Takeda-backed Ascentage Pharma aims to raise $126 mln in US IPO

Ascentage Pharma International

23/01/2025 23:52

Jan 23 (Reuters) - Ascentage Pharma  6855.HK  said on
Thursday it aims to raise $126.4 million in an initial public
offering in the U.S., becoming the first sizeable Chinese firm
to seek a listing in the United States this year.

 (Reporting by Gursimran Kaur in Bengaluru; Editing by
Subhranshu Sahu)
 ((GursimranKaur.Mehar@thomsonreuters.com, https://x.com/GursimranKMehar;))